Precise in Vivo Inflammation Imaging Using in Situ Responsive Cross‐linking of Glutathione‐Modified Ultra‐Small NIR‐II Lanthanide Nanoparticles

Mengyao Zhao,Rui Wang,Benhao Li,Yong Fan,Yifan Wu,Xinyan Zhu,Fan Zhang
DOI: https://doi.org/10.1002/anie.201812878
2019-01-01
Angewandte Chemie
Abstract:To improve the bioimaging signal-to-noise ratio (SNR), long-term imaging capability, and decrease the potential biotoxicity, an in vivo cross-linking strategy was developed by using sub-10 nm, glutathione-modified, lanthanide nanoprobes. After administration, the nanoprobes cross-link in response to reactive oxygen species (ROS) at the inflamed area and enable the quick imaging of ROS in the second near-infrared (NIR-II) window. These nanoprobes could be rapidly excreted due to their ultra-small size. This strategy may also be applied to other ultra-small contrast agents for the precise bioimaging by in situ lesion cross-linking.
What problem does this paper attempt to address?